PKD1 Gene Sequencing Test for Autosomal Dominant Polycystic Kidney Disease Type 1 (ADPKD1) in UAE | 2,800 AED | 2026 DHA Guidelines

تحليل جين PKD1 لمرض الكلى المتعدد الكيسات من النوع الأول السائد جسدياً في الإمارات | 2,800 درهم | وفق توجيهات هيئة الصحة بدبي 2026

Executive Summary & Trust Guarantees

Accuracy Guarantee: >99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.

فحص جين PKD1 بتقنية التسلسل الجيني المتقدم (NGS) لتشخيص مرض الكلى المتعدد الكيسات من النوع الأول السائد جسدياً، مع خدمات سحب منزلي متميزة ونتائج عالية الدقة تحت إشراف أطباء معتمدين من هيئة الصحة بدبي وفق القانون الإماراتي.

Test Overview & Diagnostic Precision

English

The PKD1 Gene Sequencing Test is a comprehensive NGS-based analysis that detects pathogenic variants in the PKD1 gene, the most common cause of autosomal dominant polycystic kidney disease (ADPKD). This test provides definitive molecular diagnosis, enables pre-symptomatic screening, and guides personalized management for affected families.

العربية

يعدّ تحليل جين PKD1 اختباراً جينياً متطوراً لتحديد الطفرات المسببة لمرض الكلى المتعدد الكيسات من النوع الأول السائد جسدياً، مما يمكّن من التشخيص المبكر والاستشارة الوراثية الدقيقة وتوجيه خطة العلاج الشخصية.

Feature	Our Test (PKD1 NGS)	Traditional Panel / Sanger
Methodology	NGS – full gene sequencing & CNV analysis	Limited target regions; no large deletions/duplications
Diagnostic Sensitivity	>99.9% for point mutations & structural variants	~85–90% for point mutations; misses large rearrangements
Turnaround Time	3–4 weeks	4–8 weeks (often batched)
Variant Interpretation	2026 clinically curated ACMG/AMP guidelines	Outdated databases; manual curation

Physician Insight & Safety Protocol

“As a clinical nephrologist, I understand the anxiety that accompanies a potential diagnosis of ADPKD. This test is a powerful tool, but it must be interpreted within the full clinical context of your kidney imaging and family history. We are here to guide you through every step with compassion and scientific rigor.”

— Dr. PRABHAKAR REDDY, DHA License 61713011

⚠ Medication Advisory

Do not discontinue prescribed medication without consulting your doctor. Genetic test results do not replace ongoing renal care or antihypertensive management. Any adjustment to your therapy must be supervised by your treating nephrologist.

Patient Safety: Exclusion Criteria & Emergency Red Flags

Exclusion Criteria

Testing minors without legal guardian consent (CDS Law 2026)
Individuals unable to provide informed consent
Non‑medical/forensic or paternity testing intent
Inadequate sample collection conditions (hemolysis, contamination)

ER Red Flags – Seek Immediate Medical Attention

Sudden, severe flank or abdominal pain
Gross hematuria (visible blood in urine)
Acute onset of severe headache (suspected intracranial aneurysm)
Uncontrolled hypertension with neurological symptoms

Patient FAQ & Clinical Guidance

1. What is the clinical utility of the PKD1 genetic test?

Snippet: The PKD1 NGS test identifies disease‑causing mutations, enabling accurate diagnosis, pre‑symptomatic testing, and informed family planning for autosomal dominant polycystic kidney disease type 1. This empowers nephrologists to stratify risk, initiate early monitoring, and offer reproductive options.

يكتشف تحليل PKD1 الطفرات المسببة للمرض، مما يوفر تشخيصاً دقيقاً وفحصاً قبل ظهور الأعراض، ويساعد في التخطيط العائلي السليم.

2. How is the sample collected, and is a hospital visit necessary?

Snippet: Our VIP mobile phlebotomy service collects a simple blood or buccal swab sample at your home or office, with cold‑chain logistics ensuring sample integrity from 8 AM to 11 PM. No hospital visit is required; a trained phlebotomist arrives with a sterile kit and completes the collection in under 10 minutes.

لا تحتاج لزيارة المستشفى؛ يقوم فريق التمريض المتنقل بسحب العينة من منزلك أو مكتبك بطريقة آمنة ومعقمة مع سلسلة تبريد موثقة.

3. What is the turnaround time and reporting process?

Snippet: Results are delivered in 3 to 4 weeks in a secure, DHA‑compliant digital report, with optional telephonic post‑ consultation from our clinical genetics team. The report includes variant classification, clinical significance, and recommendations for further clinical correlation.

تصدر النتائج خلال 3 إلى 4 أسابيع عبر تقرير رقمي آمن مطابق لمعايير هيئة الصحة بدبي، ويمكنك حجز استشارة هاتفية بعد الفحص.

دعم ثنائي اللغة متاح